Perspective Therapeutics, Inc. — Director's Dealing 2011

Jun 9, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-06-07

Reporting Person: Babcock Dwight William (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-07	Stock Options	$0.99	A	100000	Acquired	2021-06-07	Common Stock (100000)	Direct

Footnotes

F1: (right to buy)